May 3 |
Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024
|
Mar 15 |
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript
|
Mar 15 |
PLX: Elfabrio Geographic Expansion
|
Mar 14 |
Protalix BioTherapeutics, Inc. (PLX) Q4 2023 Earnings Call Transcript
|
Mar 14 |
Protalix BioTherapeutics Inc Reports Revenue Growth and Net Income Gain in FY 2023
|
Mar 14 |
Protalix BioTherapeutics GAAP EPS of $0.09 misses by $0.01, revenue of $65.49M beats by $1.54M
|
Mar 14 |
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
|
Mar 14 |
Earnings Scheduled For March 14, 2024
|
Mar 13 |
Protalix BioTherapeutics FY Earnings Preview
|
Mar 7 |
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024
|